These findings highlighted the association between altered BA profiles and DGAN in patients with T2DM. Combining BA profiling with conventional clinical data could facilitate the early identification of DGAN and offer new insights into early screening and BA-targeted interventions. While these findings offer valuable insights, they should nevertheless be viewed as hypothesis-generating and require further validation in larger, multicenter cohorts.
Zhu et al. (Fri,) studied this question.